Lenzilumab (Anti-CSF2 / GM-CSF)
Product Specifications
CAS Number
1229575-09-0
Synonyms
KB 003
Target
SARS-CoV
Applications
Microbiology
Additionnal Information
Lenzilumab (Anti-CSF2 / GM-CSF) is a recombinant monoclonal antibody against the cytokine granulocyte macrophage colony-stimulating factor (GM-CSF), with potential immunomodulating activity. MW: 145.72 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog